Frank D. Lee
CIK 1814686 · Chief Executive Officer · last filed 2026-05-26
Frank D. Lee is a Chief Executive Officer who has filed 24 SEC Form 4 insider transactions across 4 companies since 2020. The most recent filing, for BHC, was dated May 26, 2026. Across all open-market trades the lifetime net is −$330.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $17.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$17.13M
4
24
-$330.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BHC | Director | 95,210 | $6.25 | $595.1K | -$254.7K | 5 | 2026-05-26 |
| PCRX | Chief Executive Officer | 660,830 | $25.02 | $16.53M | $100.0K | 7 | 2026-02-13 |
| BOLT | Director | — | $4.05 | — | $0 | 5 | 2024-06-14 |
| Forma Therapeutics Holdings, Inc. (FMTX) Delisted | President and CEO | 0 | $20.01 | $0 | -$175.8K | 5 | 2022-10-14 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | BHC | Grant (A) | +45,871 | $0 | EDGAR |
| 2026-05-20 | BHC | Sell (S) | −24,456 | -$132.8K | EDGAR |
| 2026-05-19 | BHC | Notice (144) | −24,456 | -$132.8K | EDGAR |
| 2026-02-13 | PCRX | Grant (A) | +261,818 | $0 | EDGAR |
| 2026-02-03 | PCRX | Tax (F) | −41,488 | -$852.2K | EDGAR |
| 2026-01-06 | PCRX | Tax (F) | −9,272 | -$226.8K | EDGAR |
| 2025-08-22 | BHC | Sell (S) | −15,912 | -$121.9K | EDGAR |
| 2025-08-21 | BHC | Notice (144) | −15,912 | -$121.9K | EDGAR |
| 2025-05-20 | BHC | Grant (A) | +54,347 | $0 | EDGAR |
| 2025-02-04 | PCRX | Grant (A) | +350,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.